Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P-A Hauss

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Revue Des Maladies Respiratoires|March 24, 2012
[Clomipramine hypersensitivity with predominantly pulmonary involvement]J Gallego, P-A Hauss, M Salaün, et al.
Revue Des Maladies Respiratoires|June 18, 2019
[Second- or third-line treatment with erlotinib in EGFR wild-type non-small cell lung cancer: Real-life data]D Debieuvre, L Moreau, M Coudert, et al.
ESMO Open|June 7, 2024
Risk factors for early mortality from lung cancer: evolution over the last 20 years in the French nationwide KBP cohortsT C T Hoang, D Debieuvre, A-S Bravard, et al.
ESMO Open|November 28, 2024
Lurbinectedin in extensive-stage small-cell lung cancer: a brief report of the IFCT-2105 LURBICLIN studyN Girard, F Guisier, A Swalduz, et al.
Orphanet Journal of Rare Diseases|May 26, 2020
Lung function in Birt-Hogg-Dubé syndrome: a retrospective analysis of 96 patientsC Daccord, V Cottin, G Prévot, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Revue Des Maladies Respiratoires|March 24, 2012
[Clomipramine hypersensitivity with predominantly pulmonary involvement]J Gallego, P-A Hauss, M Salaün, et al.
Revue Des Maladies Respiratoires|June 18, 2019
[Second- or third-line treatment with erlotinib in EGFR wild-type non-small cell lung cancer: Real-life data]D Debieuvre, L Moreau, M Coudert, et al.
ESMO Open|June 7, 2024
Risk factors for early mortality from lung cancer: evolution over the last 20 years in the French nationwide KBP cohortsT C T Hoang, D Debieuvre, A-S Bravard, et al.
ESMO Open|November 28, 2024
Lurbinectedin in extensive-stage small-cell lung cancer: a brief report of the IFCT-2105 LURBICLIN studyN Girard, F Guisier, A Swalduz, et al.
Orphanet Journal of Rare Diseases|May 26, 2020
Lung function in Birt-Hogg-Dubé syndrome: a retrospective analysis of 96 patientsC Daccord, V Cottin, G Prévot, et al.
Pageof 1